BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16511075)

  • 1. Crystallization and preliminary X-ray crystallographic analysis of yeast NAD+-specific isocitrate dehydrogenase.
    Hu G; Taylor AB; McAlister-Henn L; Hart PJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 May; 61(Pt 5):486-8. PubMed ID: 16511075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and physiological effects of alterations in homologous isocitrate-binding sites of yeast NAD(+)-specific isocitrate dehydrogenase.
    Lin AP; McCammon MT; McAlister-Henn L
    Biochemistry; 2001 Nov; 40(47):14291-301. PubMed ID: 11714283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for half-site ligand binding in yeast NAD(+)-specific isocitrate dehydrogenase.
    Lin AP; McAlister-Henn L
    Biochemistry; 2011 Sep; 50(38):8241-50. PubMed ID: 21861471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous binding sites in yeast isocitrate dehydrogenase for cofactor (NAD+) and allosteric activator (AMP).
    Lin AP; McAlister-Henn L
    J Biol Chem; 2003 Apr; 278(15):12864-72. PubMed ID: 12562755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isocitrate binding at two functionally distinct sites in yeast NAD+-specific isocitrate dehydrogenase.
    Lin AP; McAlister-Henn L
    J Biol Chem; 2002 Jun; 277(25):22475-83. PubMed ID: 11953438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel allosteric properties produced by residue substitutions in the subunit interface of yeast NAD+-specific isocitrate dehydrogenase.
    Hu G; McAlister-Henn L
    Arch Biochem Biophys; 2006 Sep; 453(2):207-16. PubMed ID: 16884682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding and structural changes associated with allostery in yeast NAD(+)-specific isocitrate dehydrogenase.
    McAlister-Henn L
    Arch Biochem Biophys; 2012 Mar; 519(2):112-7. PubMed ID: 22008468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization and preliminary X-ray diffraction studies of monomeric isocitrate dehydrogenase by the MAD method using Mn atoms.
    Yasutake Y; Watanabe S; Yao M; Takada Y; Fukunaga N; Tanaka I
    Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1682-5. PubMed ID: 11679744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit interactions of yeast NAD+-specific isocitrate dehydrogenase.
    Panisko EA; McAlister-Henn L
    J Biol Chem; 2001 Jan; 276(2):1204-10. PubMed ID: 11042198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of NAD(+)-isocitrate dehydrogenase with altered isocitrate binding sites: contribution of IDH1 and IDH2 subunits to regulation and catalysis.
    Cupp JR; McAlister-Henn L
    Biochemistry; 1993 Sep; 32(36):9323-8. PubMed ID: 8369302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of AMP on mRNA binding by yeast NAD+-specific isocitrate dehydrogenase.
    Anderson SL; Schirf V; McAlister-Henn L
    Biochemistry; 2002 Jun; 41(22):7065-73. PubMed ID: 12033940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and preliminary X-ray structure analysis of isocitrate dehydrogenase from two hyperthermophiles, Aeropyrum pernix and Thermotoga maritima.
    Karlström M; Steen IH; Tibbelin G; Lien T; Birkeland NK; Ladenstein R
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2162-4. PubMed ID: 12454487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the inhibitory mechanisms of NADH on the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase.
    Liu Y; Hu L; Ma T; Yang J; Ding J
    Sci Rep; 2018 Feb; 8(1):3146. PubMed ID: 29453450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of porcine mitochondrial NADP+-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate. Insights into the enzyme mechanism.
    Ceccarelli C; Grodsky NB; Ariyaratne N; Colman RF; Bahnson BJ
    J Biol Chem; 2002 Nov; 277(45):43454-62. PubMed ID: 12207025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the function of the αβ heterodimer of human NAD-dependent isocitrate dehydrogenase.
    Sun P; Ma T; Zhang T; Zhu H; Zhang J; Liu Y; Ding J
    J Biol Chem; 2019 Nov; 294(44):16214-16227. PubMed ID: 31515270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of the allosteric regulation of the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase.
    Ma T; Peng Y; Huang W; Ding J
    Sci Rep; 2017 Jan; 7():40921. PubMed ID: 28098230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric motions in structures of yeast NAD+-specific isocitrate dehydrogenase.
    Taylor AB; Hu G; Hart PJ; McAlister-Henn L
    J Biol Chem; 2008 Apr; 283(16):10872-80. PubMed ID: 18256028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and analyses of tetrameric forms of yeast NAD+-specific isocitrate dehydrogenase.
    Lin AP; Demeler B; Minard KI; Anderson SL; Schirf V; Galaleldeen A; McAlister-Henn L
    Biochemistry; 2011 Jan; 50(2):230-9. PubMed ID: 21133413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of interactions with mitochondrial mRNA using mutant forms of yeast NAD(+)-specific isocitrate dehydrogenase.
    Anderson SL; Lin AP; McAlister-Henn L
    Biochemistry; 2005 Dec; 44(50):16776-84. PubMed ID: 16342968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical Characterization and Crystal Structure of a Novel NAD
    Huang SP; Zhou LC; Wen B; Wang P; Zhu GP
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.